Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
Allogene Therapeutics, Inc. (ALLO)
|
|
Operating Efficiency |
|
|
|
|
Annual |
|
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-05-18 |
| Source | Source | Source | Source | Source | Source |
Turnover Ratios |
Asset turnover | 0.0 | 0.0 | 0.0 | 0.0 | | |
|
Returns on Capital |
ROIC (excluding intangibles) | -43.9% | -28.7% | -35.0% | -34.4% | | |
ROIC (including intangibles) | -47.7% | -31.0% | -26.9% | -38.9% | -29.4% | |
ROE | -50.4% | -27.9% | -23.9% | -32.1% | -27.4% | |
ROA | -41.1% | -24.6% | -21.0% | -28.1% | -24.9% | |
|
Cash Conversion Cycle |
Days sales outstanding | 0.0 | 0.0 | | | | |
|